These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 30453246)

  • 21. Parasite prolyl oligopeptidases and the challenge of designing chemotherapeuticals for Chagas disease, leishmaniasis and African trypanosomiasis.
    Bastos IM; Motta FN; Grellier P; Santana JM
    Curr Med Chem; 2013; 20(25):3103-15. PubMed ID: 23514419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitors of dihydrofolate reductase in Leishmania and trypanosomes.
    Gilbert IH
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):249-57. PubMed ID: 12084467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis.
    World Health Organization
    World Health Organ Tech Rep Ser; 2012; (975):v-xii, 1-100. PubMed ID: 23484340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flavonoids as efficient scaffolds: Recent trends for malaria, leishmaniasis, Chagas disease, and dengue.
    Boniface PK; Ferreira EI
    Phytother Res; 2019 Oct; 33(10):2473-2517. PubMed ID: 31441148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterocyclic N-oxides - A Promising Class of Agents against Tuberculosis, Malaria and Neglected Tropical Diseases.
    Dos Santos Fernandes GF; Pavan AR; Dos Santos JL
    Curr Pharm Des; 2018; 24(12):1325-1340. PubMed ID: 29663875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiprotozoal compounds: state of the art and new developments.
    Astelbauer F; Walochnik J
    Int J Antimicrob Agents; 2011 Aug; 38(2):118-24. PubMed ID: 21549569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. π-Delocalized Lipophilic Cations as New Candidates for Antimalarial, Antitrypanosomal and Antileishmanial Agents: Synthesis, Evaluation of Antiprotozoal Potency, and Insight into Their Action Mechanisms.
    Takasu K
    Chem Pharm Bull (Tokyo); 2016; 64(7):656-67. PubMed ID: 27373622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological approaches to antitrypanosomal chemotherapy.
    Croft SL
    Mem Inst Oswaldo Cruz; 1999; 94(2):215-20. PubMed ID: 10224531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of Flavanones as Scaffolds for the Development of New Treatments against Malaria and African and American Trypanosomiases.
    Boniface PK; Ferreira EI; Fabrice FB
    Mini Rev Med Chem; 2023; 23(14):1479-1498. PubMed ID: 36582061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infectious diseases. Overcoming neglect of kinetoplastid diseases.
    Bilbe G
    Science; 2015 May; 348(6238):974-6. PubMed ID: 26023124
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of trypanosomiasis and leishmaniasis.
    Barrett MP; Croft SL
    Br Med Bull; 2012; 104(1):175-96. PubMed ID: 23137768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hybrid Molecules: Promising Compounds for the Development of New Treatments Against Leishmaniasis and Chagas Disease.
    Cardona-G W; Yepes AF; Herrera-R A
    Curr Med Chem; 2018; 25(30):3637-3679. PubMed ID: 29521209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computer-Aided Drug Discovery Approaches against the Tropical Infectious Diseases Malaria, Tuberculosis, Trypanosomiasis, and Leishmaniasis.
    Njogu PM; Guantai EM; Pavadai E; Chibale K
    ACS Infect Dis; 2016 Jan; 2(1):8-31. PubMed ID: 27622945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
    de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Organometallic compounds in the discovery of new agents against kinetoplastid-caused diseases.
    Ravera M; Moreno-Viguri E; Paucar R; Pérez-Silanes S; Gabano E
    Eur J Med Chem; 2018 Jul; 155():459-482. PubMed ID: 29908440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent Advances in the Synthesis and Development of Nitroaromatics as Anti-Infective Drugs.
    Kannigadu C; N'Da DD
    Curr Pharm Des; 2020; 26(36):4658-4674. PubMed ID: 32228417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neglected Tropical Protozoan Diseases: Drug Repositioning as a Rational Option.
    Sbaraglini ML; Vanrell MC; Bellera CL; Benaim G; Carrillo C; Talevi A; Romano PS
    Curr Top Med Chem; 2016; 16(19):2201-22. PubMed ID: 26881713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening the Medicines for Malaria Venture Pathogen Box across Multiple Pathogens Reclassifies Starting Points for Open-Source Drug Discovery.
    Duffy S; Sykes ML; Jones AJ; Shelper TB; Simpson M; Lang R; Poulsen SA; Sleebs BE; Avery VM
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteasome as a Drug Target in Trypanosomatid Diseases.
    Silva ML; de Santiago-Silva KM; Fabris M; Camargo PG; de Lima Ferreira Bispo M
    Curr Drug Targets; 2023; 24(10):781-789. PubMed ID: 37469152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiprotozoal Thiazoles. 2-(5-Nitro-2-thienyl)thiazoles.
    Verge JP; Roffey P
    J Med Chem; 1975 Aug; 18(8):794-7. PubMed ID: 808611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.